{"nct_id":"NCT04980391","title":"A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers","status":"TERMINATED","status_verified_date":"2025-03","start_date":"2021-08-03","start_date_type":"ACTUAL","primary_completion_date":"2023-05-30","primary_completion_date_type":"ACTUAL","completion_date":"2023-05-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}